Literature DB >> 22101232

Nanoparticles for intracellular-targeted drug delivery.

Cristiana S O Paulo1, Ricardo Pires das Neves, Lino S Ferreira.   

Abstract

Nanoparticles (NPs) are very promising for the intracellular delivery of anticancer and immunomodulatory drugs, stem cell differentiation biomolecules and cell activity modulators. Although initial studies in the area of intracellular drug delivery have been performed in the delivery of DNA, there is an increasing interest in the use of other molecules to modulate cell activity. Herein, we review the latest advances in the intracellular-targeted delivery of short interference RNA, proteins and small molecules using NPs. In most cases, the drugs act at different cellular organelles and therefore the drug-containing NPs should be directed to precise locations within the cell. This will lead to the desired magnitude and duration of the drug effects. The spatial control in the intracellular delivery might open new avenues to modulate cell activity while avoiding side-effects.

Mesh:

Substances:

Year:  2011        PMID: 22101232     DOI: 10.1088/0957-4484/22/49/494002

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  28 in total

Review 1.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 2.  Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

Authors:  Sibel Bozdağ Pehlivan
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

3.  Ligand-directed profiling of organelles with internalizing phage libraries.

Authors:  Andrey S Dobroff; Roberto Rangel; Liliana Guzman-Roja; Carolina C Salmeron; Juri G Gelovani; Richard L Sidman; Cristian G Bologa; Tudor I Oprea; C Jeffrey Brinker; Renata Pasqualini; Wadih Arap
Journal:  Curr Protoc Protein Sci       Date:  2015-02-02

Review 4.  Nanomedicines in gastroenterology and hepatology.

Authors:  Alf Lamprecht
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-10       Impact factor: 46.802

Review 5.  Integrating optogenetic and pharmacological approaches to study neural circuit function: current applications and future directions.

Authors:  Garret D Stuber; Alex O Mason
Journal:  Pharmacol Rev       Date:  2013-01-10       Impact factor: 25.468

6.  Optimized lysis buffer reagents for solubilization and preservation of proteins from cells and tissues.

Authors:  Byeong Hee Hwang; Kenneth Y Tsai; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

7.  N-Doped graphene quantum dot@mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery.

Authors:  Wenying Gui; Jinrui Zhang; Xueqian Chen; Dahai Yu; Qiang Ma
Journal:  Mikrochim Acta       Date:  2017-12-18       Impact factor: 5.833

8.  Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer.

Authors:  Garima Sharma; Jongbong Park; Ashish Ranjan Sharma; Jun-Sub Jung; Haesung Kim; Chiranjib Chakraborty; Dong-Keun Song; Sang-Soo Lee; Ju-Suk Nam
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

9.  Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.

Authors:  Siva P Kambhampati; Manoj K Mishra; Panagiotis Mastorakos; Yumin Oh; Gerard A Lutty; Rangaramanujam M Kannan
Journal:  Eur J Pharm Biopharm       Date:  2015-02-19       Impact factor: 5.571

10.  Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.

Authors:  Ye Yuan; Si Chen; Tatjana Paunesku; Sophie Charlotte Gleber; William C Liu; Caroline B Doty; Rachel Mak; Junjing Deng; Qiaoling Jin; Barry Lai; Keith Brister; Claus Flachenecker; Chris Jacobsen; Stefan Vogt; Gayle E Woloschak
Journal:  ACS Nano       Date:  2013-11-27       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.